Daiichi Sankyo, GSK Agree to Set Up Joint Venture in Vaccine Business

Executives of Daiichi Sankyo and GSK K.K. Daiichi Sankyo and GlaxoSmithKline K.K. (GSK) announced on March 2 that they had agreed to set up a joint venture, “Japan Vaccine Co., Ltd.”, for vaccine development and marketing in Japan. In addition...read more